35
Views
1
CrossRef citations to date
0
Altmetric
Papers

Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection

, &
Pages 433-445 | Received 13 Feb 2007, Accepted 18 May 2007, Published online: 10 Jul 2009
 

Abstract

Type I interferon (IFN) is critical for resistance of mice to infection with vesicular stomatitis virus (VSV). Wild type (wt) VSV infection did not induce type I IFN production in vitro or in the central nervous system (CNS) of mice; however IFN-β was detected in lungs, spleen, and serum within 24 h. The M protein mutant VSV, T1026R1 (also referred to as M51R), induced type I IFN production in vitro and in the CNS, with poor expression in spleens. In addition, VSV T1026R1 was not pathogenic to mice after intranasal infection, illustrating the importance of IFN in controlling VSV replication in the CNS. Experiments with chemical sympathectomy, sRAGE, and neutralizing antibody to VSV were performed to investigate the mechanism(s) utilized for induction of peripheral IFN; neither sRAGE infusion nor chemical sympathectomy had an effect on peripheral IFN production. In contrast, administration of neutralizing antibody (Ab) readily blocked the response. Infectious VSV was transiently present in lungs and spleens at 24 h post infection. The results are consistent with VSV traffic from the olfactory neuroepithelium to peripheral lymphoid organs hematogenously or via lymphatic circulation. These results suggest that VSV replicates to high titers in the brains of mice because of the lack of IFN production in the CNS after intranasal VSV infection. In contrast, replication of VSV in peripheral organs is controlled by the production of large amounts of IFN.

The current address of Mark D. Trottier is Biochemistry and Molecular Biology Department, Michigan State University, East Lansing, Michigan, USA.

The authors are very appreciative of Peter Palese and Neva Morales (Mt Sinai School of Medicine) for providing NDV, Laurent Poliquin (University of Quebec) for providing T1026R1 virus, and Ann Marie Schmidt (College of Physicians & Surgeons, Columbia University) for sRAGE. Valuable conversations with Akiko Iwasaki (Yale University), V. Hugh Perry (University of Southampton), and Susan Morgello (Mt. Sinai School of Medicine) during the course of this work provided insights and are gratefully acknowledged. Technical support was provided by Marta Crowe and Ernest Yakob. Paul M. D'Agostino assisted in preparation of some figures. This work was supported by postdoctoral fellowship NS11073 to M.D.T. and a Research Challenge Fund award N5385 from New York University, and DC003536 and NS039746 to C.S.R.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.